Baird Financial Group’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,999
Closed -$293K 1752
2024
Q3
$293K Sell
6,999
-785
-10% -$32.6K ﹤0.01% 1547
2024
Q2
$318K Buy
7,784
+174
+2% +$6.92K ﹤0.01% 1541
2024
Q1
$315K Buy
7,610
+448
+6% +$18.8K ﹤0.01% 1537
2023
Q4
$290K Buy
+7,162
New +$274K ﹤0.01% 1531

Other funds holding BME

Baird Financial Group's BME Position: Q4 2024 in Review

Baird Financial Group sold out of BlackRock Health Sciences Trust (BME) in Q4 2024, closing a stake of 6,999 shares — an estimated $293K sold.

Baird Financial Group first reported a position in BME in Q4 2023 and held it in 4 quarters. The position peaked at $318K in Q2 2024. 73 funds tracked by Wall St. Rank hold BME as of Q4 2024.

  • Baird Financial Group reported no remaining BlackRock Health Sciences Trust position as of Q4 2024 after selling out during the quarter.
  • Baird Financial Group sold 6,999 BlackRock Health Sciences Trust shares in Q4 2024, an estimated $293K.
  • Baird Financial Group first reported a position in BlackRock Health Sciences Trust in Q4 2023 and held it in 4 quarters.
  • Baird Financial Group's BlackRock Health Sciences Trust position peaked at $318K in Q2 2024.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2024.

Based on Baird Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.